| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TG-101348 | GDSC1000 | pan-cancer | AAC | 0.055 | 0.08 |
| mRNA | CR-1-31B | CTRPv2 | pan-cancer | AAC | 0.062 | 0.08 |
| mRNA | B02 | CTRPv2 | pan-cancer | AAC | 0.07 | 0.08 |
| mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | 0.068 | 0.08 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | 0.061 | 0.08 |
| mRNA | BRD-K29313308 | CTRPv2 | pan-cancer | AAC | 0.071 | 0.08 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | -0.071 | 0.08 |
| mRNA | GDC-0449 | GDSC1000 | pan-cancer | AAC | -0.069 | 0.08 |
| mRNA | CAY10603 | GDSC1000 | pan-cancer | AAC | 0.058 | 0.08 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | 0.059 | 0.08 |